Your global diagnostic partner of choice
With more high medical value assay approvals achieved than any other competitor, Roche Personalised Healthcare Solutions (PHCS) has earned a reputation that makes us the #1 global diagnostic partner of choice. Our dedicated partnering team provides a single point of access to multiple, integrated technologies to help expedite the execution of your biomarker and diagnostic strategy, strengthened by regulatory and medical capabilities across the globe. Adding to this the largest presence of instruments in labs worldwide and our deep collective experience in overcoming obstacles to efficiently advance the delivery of vital therapies, we are uniquely positioned to deliver on all your diagnostic needs.
New to Roche?
About Roche Personalised Healthcare Solutions (PHCS)
In collaboration with leading pharmaceutical companies, we help to advance precision medicine by innovating and developing high medical value diagnostics that transform the lives of patients across disease areas. Our solutions enable reliable results and rapid turnaround time, empowering clinicians with essential information to guide timely, personalized treatment strategies. With medical, scientific, regulatory, and marketing expertise, we support pharma partners at all stages from assay development to commercialization and launch.
Assay Portfolio
Roche PHCS offers partners access to a menu of more than 500 non-exclusive assays spanning multiple disease areas, connecting you with innovative solutions that are already performing in today’s market, as well as dozens of clinical trial ready assays, and a wide array of unique biomarkers already validated in Roche’s CAP/CLIA labs. With more than 340 active clinical trials and 65+ global IVD registration studies underway, Roche PHCS can deliver expert support for the widest range of diagnostic solutions across IHC/ISH and digital pathology, PCR, NGS, and immunoassay technologies.
Development Process
Our proven, end-to-end development solution provides partners with flexibility and confidence. Roche PHCS’ rigorous, disciplined approach to biomarker research, testing, assay verification and validation, and clinical trial support maximizes the probability of successful IVD development. Our full spectrum of pharma services capabilities allows us to easily customize assays to any drug development phase. We are active in clinical trial enrollment and have developed strategies to support your clinical research in neurology, oncology, general medicine and more.
